Allstate Investment Management’s Edwards Lifesciences EW Stock Holding History

Allstate Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.51M	Buy	+20,299	New	+$1.56M	0.05%	257

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Allstate Investment Management's EW Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Edwards Lifesciences (EW) in Q4 2022: 20,299 shares worth $1.51M. The stake represents 0.05% of the portfolio and ranks #257 among its holdings.

1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Allstate Investment Management held 20,299 shares of Edwards Lifesciences worth $1.51M as of Q4 2022.
Edwards Lifesciences was a new Allstate Investment Management position in Q4 2022.
Edwards Lifesciences made up 0.05% of Allstate Investment Management's portfolio in Q4 2022, its #257 holding.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.